AI in Healthcare

Leslie Orne, President and CEO of Trinity Life Sciences — Life Sciences Innovations, Data-Driven Strategies, AI in Pharma, Executive Leadership, Strategic Transactions, Brand Planning, and Executive Work-Life Balance

We thank Leslie Orne, the President and CEO of Trinity Life Sciences, for sharing her insights with us in this exclusive interview. Trinity Life Sciences is a company at the forefront of providing strategic solutions in the life sciences industry. With her extensive experience in the sector, Leslie sheds light on the latest technological innovations, …

Leslie Orne, President and CEO of Trinity Life Sciences — Life Sciences Innovations, Data-Driven Strategies, AI in Pharma, Executive Leadership, Strategic Transactions, Brand Planning, and Executive Work-Life Balance Read More »

National Heart Centre Singapore Launches AI Lab for Cardiac Imaging

“We are excited to spearhead research on the use of AI in the clinical setting. AI can potentially capture and make sense of complex image information in a multidimensional manner, improve predictive ability, and reduce labor and time intensive processes.” Assistant Professor Lohendran Baskaran, Clinical Lead, Cardiovascular Systems Imaging and AI Lab, NHCS On March …

National Heart Centre Singapore Launches AI Lab for Cardiac Imaging Read More »

Highlights From The Riyadh Global Summit for Artificial Intelligence In Healthcare

This weekend the Riyadh Global Summit for Artificial Intelligence In Healthcare took place in The Kingdom of Saudi Arabia. Leading AI scientists, Pharma executives, and business leaders from around the world came together to explore the potential of AI, machine learning, and deep learning in healthcare. Distinguished speakers attended from The Kingdom of Saudi Arabia, …

Highlights From The Riyadh Global Summit for Artificial Intelligence In Healthcare Read More »

Major Milestone Reached: First AI-Developed Drug Enters Phase 1 Trial

“It gives me great pleasure to announce that we have completed our first human in Phase 0 clinical trial and entered the full Phase 1 clinical trial with a once-a-day oral dose of our ISM001-055 anti-fibrotic where the target was identified using AI and the molecule was designed using AI, meaning it is AI-discovered and AI-designed.“ …

Major Milestone Reached: First AI-Developed Drug Enters Phase 1 Trial Read More »

AI In Healthcare Highlights & Milestones 2021

AI in Healthcare companies are making significant progress. We’ve reached the threshold of a new era where advanced technologies will improve the way we understand, treat, and prevent disease. In 2021 the application of AI enabled advances in many areas of healthcare. We made significant progress in AI for drug discovery, medical imaging, diagnostics, pathology, …

AI In Healthcare Highlights & Milestones 2021 Read More »

Scroll to Top